Epidemiology of Leptospirosis in Costa Rica 2011–2015

被引：4
作者：
Carvajal M.P. [1 ]
Fagerstrom K.A. [2 ]
机构：
[1] Consejería y Atención Médica, Residencia las Palmeras, casa #1, Daniel Flores, San José, Pérez Zeledón
[2] National School of Tropical Medicine, Baylor College of Medicine, 1102 Bates St. Feigin Bldg, Suite 0550, Houston, 77030, TX
来源：
Current Tropical Medicine Reports | 2017年 / 4卷 / 2期
关键词：
Control programs; Costa Rica; Epidemiology; INCIENSA (Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud); Leptospirosis; Surveillance;
D O I：
10.1007/s40475-017-0102-x
中图分类号：
学科分类号：
摘要：
Purpose of Review: Leptospirosis is a global spirochete causing chronic renal disease that is increasing in Costa Rica. This paper identifies the prevalence and risk factors of leptospirosis in Costa Rica between the years of 2011–2015. Recent Findings: Clinical cases of leptospirosis in Costa Rica demonstrated various symptoms: from asymptomatic diseases to severe cases of kidney and liver failure. A variety of diagnostic methods with varying specificities and sensitivities were employed. In Costa Rica, prevention methods such as protective clothing, decreased contact with animals, and prophylaxis of close contacts continue to be the most important factors in reducing transmission of leptospirosis. Summary: In Costa Rica, the following populations should be aware of their increased risk: those living in the province of San José, Puntarenas, or Alajuela; being a male; being of productive years; and exposure to specific environmental factors. © 2017, The Author(s).
引用
收藏
页码：41 / 46
页数：5
相关论文
共 19 条
  • [1] Douglas, and Bennett, Principles and practice of infectious diseases
  • [2] Douglas, and Bennett, Principles and practice of infectious diseases
  • [3] Haake S.D.A., Levette P.N., Leptospirosis in humans, Curr Top Microbiol Immunol, 387, pp. 65-97, (2015)
  • [4] SENASA, Informe sobre la situación sanitaria de Costa Rica, (2012)
  • [5] Torgerson P.R., Hagan J.E., Costa F., Calcagno J., Kane M., Martinez-Silveira M.S., Goris M.G.A., Stein C., Ko A.I., Abela-Ridder B., Global burden of leptospirosis: estimated in terms of disability adjusted life years, PLoS Negl Trop Dis, (2015)
  • [6] Protocolo para la prevención y control de la leptospirosis, (2002)
  • [7] Yang B., de Vries S.G., Visser B.J., Nagel I.M., Goris M.G., Leeflang M.M., Et al., Molecular and antigen detection tests for leptospirosis, Cochrane Database Syst Rev, (2015)
  • [8] Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, INCIENSA, (2011)
  • [9] Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, INCIENSA, (2012)
  • [10] Cespedes A.P., Leptospirosis: una enfermedad reemergente, Pharm Care Farm, 2, pp. 40-47, (2012)
12